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The human papillomavirus type 16 E5 oncoprotein possesses mitogenic activity that acts synergistically with
epidermal growth factor (EGF) in human keratinocytes and inhibits the degradation of the EGF receptor in
endosomal compartments after ligand-stimulated endocytosis. One potential explanation for these observa-
tions is that E5 inhibits the acidification of endosomes. This may be mediated through the 16-kDa component
of the vacuolar proton-ATPase, since animal and human papillomavirus E5 proteins bind this subunit protein.
Using a ratio-imaging technique to determine endosomal pH, we found that the acidification of endosomes in
E5-expressing keratinocytes was delayed at least fourfold compared with normal human keratinocytes and
endosomes in some cells never completely acidified. Furthermore, E5 expression increased the resistance of
keratinocytes to protein synthesis inhibition by diphtheria toxin, a process dependent on efficient endosomal
acidification. Finally, artificially inhibiting endosomal acidification with chloroquine during the endocytosis of
EGF receptors in keratinocytes demonstrated many of the same effects as the expression of human papillo-
mavirus type 16 E5, including prolonged retention of undegraded EGF receptors in intracellular vesicles.
Human papillomaviruses (HPVs) infect basal human kera-
tinocytes and propagate in the differentiating layers of the
epithelium (25). The E6, E7, and E5 proteins possess onco-
genic activities that contribute to the pathogenesis associated
with HPV infection (7, 19, 21, 23, 34, 42). Of particular interest
are the genital HPV types with pathogenic effects ranging in
severity from benign neoplasia, as with HPV type 6 (HPV-6)
and HPV-11, to the malignant carcinomas associated with
HPV-16 and -18 (26). How these proteins contribute to the life
cycle of the virus is a matter of speculation, since the viruses
have yet to be propagated in vitro, making their study difficult.
The HPV-16 E5 open reading frame encodes a small, highly
hydrophobic protein (2) with activities that may contribute
both to the pathogenicity of the virus and to its replication.
Recent reports (19, 21, 42) have demonstrated the abilities of
HPV-16 E5 to transform murine fibroblasts and stimulate mi-
togenesis in human keratinocytes. Furthermore, these activi-
ties were enhanced specifically in the presence of epidermal
growth factor (EGF), the primary essential mitogen for kera-
tinocytes in vitro and in vivo (36). EGF is the ligand for the
EGF receptor (EGFR), a transmembrane receptor protein
present on all epithelial cells (4, 5). Ligand binding to the
extracellular domain of the receptor initiates receptor dimer-
ization and stimulates the tyrosine kinase activity of the intra-
cellular domain of the receptor (3, 4, 46), resulting in auto-
phosphorylation and the initiation of a cascade of events
leading to the stimulation of DNA synthesis (3, 6, 29). The
down-regulation of the active receptor involves the rapid mi-
gration of the ligand-receptor complex to clathrin-coated pits,
internalization via receptor-mediated endocytosis into endo-
somes, dissociation of receptor and ligand, and fusion of en-
dosomes with lysosomes in which both ligand and receptor are
degraded (3, 4, 46). Little EGFR recycles to the cell surface,
and the reappearance of EGFR at the plasma membrane fol-
lowing down-regulation involves primarily de novo synthesis
(4). We have shown (42) that the expression of HPV-16 E5 in
human keratinocytes increases the number of EGFRs at the
cell surface. In addition, HPV-16 E5 modifies the response of
these receptors to ligand, and the EGFRs are hyperphosphor-
ylated, receptor degradation is inhibited, and increased recy-
cling of receptors to the cell surface occurs. However, the
internalization and degradation of ligand occur normally in
these cells.
Another reported property of HPV-16 E5 is the ability to
bind a 16-kDa protein (9) identified as a component of a
vacuolar proton-ATPase pump complex (H1-ATPase). This
protein complex is a member of a family of H1-ATPases re-
sponsible for the acidification of a variety of compartments and
organelles in the cell, including those involved in the receptor-
mediated endocytosis of the EGFR (13, 24, 39). The 16-kDa
subunit of the mammalian H1-ATPase pump is homologous to
the yeast 17-kDa subunit, an integral membrane protein form-
ing all or part of the pore utilized for proton translocation (13,
20). Through an unknown mechanism the pump complex is
either rapidly recruited to budding endosomes or activated
through a regulatory event, since the plasma membrane of
mammalian cells is devoid of active H1-ATPase (13, 18, 39).
The pump establishes and maintains the low internal pH 4.5 to
5.0 in endosomes and lysosomes relative to the cytoplasmic pH
7.0 to 7.2 by utilizing the energy from ATP hydrolysis to gen-
erate an influx of protons into the vesicle (13, 14, 24, 39).
Acidification dissociates receptor-ligand interactions, such as
the release of nutrients from their transport proteins, and also
catalyzes the penetration of some viruses (15, 33, 35) and
toxins. Diphtheria toxin, for example, consists of a and b sub-
units: the low pH of the endosome activates the b subunit to
form a channel through the endosomal membrane that allows
the active a subunit to enter the cytoplasm (22, 32).
On the basis of the previous finding that HPV-16 E5 binds
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the 16-kDa component of the H1-ATPase pump, we sought to
determine whether HPV-16 E5 expression resulted in alter-
ation of endosomal acidification and whether this activity
might account for the alterations in EGFR metabolism previ-
ously observed in HPV-16 E5-expressing cells. All experiments
were performed with human foreskin keratinocytes, normal
host cells for HPV. These were maintained in culture with
serum-free KGM or E medium with EGF and feeder cells as
described in reference 42. Keratinocytes were transfected via
electroporation with HPV-containing plasmids and pSV2neo
as a selectable marker, from which individual clones were
isolated for analysis (42). The electroporated plasmids in-
cluded pKV16E5 (HPV-16 E5 expressed alone from the hu-
man cytomegalovirus immediate-early gene promoter [hCMV]),
pAT16E5X (full-length HPV-16 genome with a translation
termination linker inserted at bp 3879, resulting in premature
termination of the E5 protein), and pAT16 and K1/16 (full-
length HPV-16 genome with E5 expressed from the endoge-
nous promoter). Mass cultures of G418-selected keratinocytes
transduced with defective retroviral particles (multiplicity of
infection, 1 to 2; with 10 mg of Polybrene per ml) containing
either pLXSN (a vector-only control) or pLXSN16E5 (which
expresses HPV-16 E5 from the Harvey murine sarcoma virus
long terminal repeat [LTR]) were used in some assays to de-
termine the effect, if any, of vector DNA and the transfection
procedure. The pLXSN vector and the preparation of defec-
tive amphotropic retrovirus using the packaging cell line
PA317 are described in references 27 and 28. Human foreskin
keratinocytes and mass cultures were used prior to the fifth
passage. All cell lines were used at early passages (passage 25
or earlier), except for K1/16 cells, which were used at passage
240 or greater. Several clones of each transfectant, multiple
keratinocyte isolates, and several mass cultures were tested at
different passages, and the results were pooled for analysis and
presentation.
Transfected clones were analyzed by Northern (RNA) blot
hybridization to detect HPV-16 E5 in transcripts (Fig. 1). Total
cellular RNA was prepared by an AGPCmethod adapted from
Chomczynski and Sacchi (8) and separated on a 7% formal-
dehyde–0.8% agarose gel. The RNA was loaded in buffer con-
taining ethidium bromide, and the resulting gel is shown in Fig.
1A, which shows the relatively even loading of the RNA be-
tween wells. HPV-16 E5 mRNA expression was determined
after transfer of the RNA to nitrocellulose and Northern blot
with a radiolabeled HPV-16 E5 RNA probe made from
pGEM16E5 by using the in vitro transcription kit from Pro-
mega Corporation (Madison, Wis.). The E5-containing mes-
sages expressed from the vectors used in the subsequently
described experiments are shown in Fig. 1B. The vector control
plasmid pLXSN does not show any E5-specific message (lane
4), while the pLXSN16E5-containing cells express an E5-con-
taining mRNA of approximately 3 kbp from the LTR (lanes 1
to 3). The pKV16E5 clone expresses an E5 message of approx-
imately 1.5 kbp from the hCMV promoter (lane 5), while the
messages from the full-length HPV DNA in pAT16E5X (lanes
6 and 7), pAT16 (lanes 8 and 9), and K1/16 (lane 10) clones are
approximately 1.4 kbp. This 1.4-kbp message corresponds to
the approximately 1.4-kbp E6*-E7-E1/E4-E5 polycistronic
message detected by Doorbar et al. (10) and Rohlfs et al. (37)
in HPV-16 containing keratinocyte cell lines. Different levels
of E5 message are clearly seen in Fig. 1B compared with the
total RNA loaded (Fig. 1A), particularly if the pLXSN16E5
mass cultures (lanes 1 to 3) are compared with the other
E5-expressing clones (lanes 5 and 8 to 10). Furthermore, the
expression of an E5 protein seems to have little effect on the
level of the polycistronic message as shown by comparison of
pAT16 clones (lanes 8 and 9) with pAT16E5X clones (lanes 6
and 7). Unfortunately, the level of HPV-16 E5 protein expres-
sion could not be determined, as there are no antibodies pres-
ently available that will detect this extremely hydrophobic pro-
tein. However, genetic proof that E5 is the causal agent of the
effects described below comes from the combination of vectors
used in this study.
Determination of endosomal pH. Initially, we wished to de-
termine whether there was a difference between the endosomal
pH of E5-expressing keratinocytes and that of normal cells. We
used a ratio-imaging technique that takes advantage of the
pH-dependent fluorescence of fluorescein molecules. Details
of the procedure and the use of digitized video microscopy for
these measurements can be found in references 16 and 51. At
the excitation wavelength of 440 nm the intensity of fluorescein
fluorescence monitored at 520 nm is independent of pH, but
the fluorescence intensity at an excitation wavelength of 490
nm rapidly decreases as the pH becomes more acidic (24, 31,
45). The ratio of these emission intensities compared with a
standard curve (pH 5 to 8) provides a pH measurement that is
independent of dye concentration and optical path length and
unaffected by photobleaching (16, 24, 45, 49, 51). We used
fluorescein isothiocyanate-dextran of low molecular weight
(average molecular weight, 9,400; Sigma Chemical Co., St.
Louis, Mo.), which is nonspecifically incorporated into clath-
rin-coated and uncoated endocytic vesicles during a 5-min in-
cubation at 378C. During label incorporation, the cells were
simultaneously treated with 100 ng of EGF per ml to stimulate
EGFR activity and internalization.
Figure 2 shows the results of the experiments to determine
the pH of endosomes in E5-containing cells. The pH values
obtained by this assay ranged from $7.0, determined at the
start of the incubation, to 5, the lowest value reportable by this
method. The acidification is reported as percent change in pH
rather than absolute pH values so that the measurements be-
tween experiments could be normalized to a common scale. In
Fig. 2A the average endosomal pH fell rapidly in normal ke-
ratinocytes and in those transfected with pAT16E5X, which
has a stop codon in E5, from $7.0 (0% change) to 5 (100%
change) in 600 to 1,200 s. Cells expressing E5 from either an
exogenous promoter or the HPV-16 genome incompletely
acidified their endosomes and required more time to do so.
pKV16E5 took four times as long as normal keratinocytes to
experience a maximal 96.9% average endosomal pH change
(at 4,800 s), and the endosomes in pAT16 and K1/16 experi-
enced only an 82.1% change and a 55.3% change in pH, re-
FIG. 1. HPV-16 E5 mRNA expression. (A) Ethidium bromide stain of total
RNA isolated from keratinocytes separated on an agarose-formaldehyde gel; (B)
autoradiograph of the Northern blot of the gel shown in panel A after hybrid-
ization with an in vitro-transcribed E5 RNA probe. Lanes: 1 to 3, separate
isolates of mass cultures of pLXSN16E5 (which expresses E5 from the Harvey
murine sarcoma virus LTR); 4, mass culture of pLXSN (a vector control); 5,
pKV16E5 clone 5 (which expresses E5 from the hCMV promoter); 6 and 7,
pAT16E5X clones 1 and 2 (full-length HPV-16 DNA containing a premature
stop codon in E5); 8 and 9, pAT16 clones 4 and 5 (full-length HPV-16 DNA); 10,
K1/16 clone 1 (full-length HPV-16 DNA).
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spectively, even after 80 min. The reduced rate of pH change
in E5-expressing cells was more evident at 1,200 s; at this time,
normal keratinocytes and pAT16E5X had completely acidified
(100% pH change), while pKV16E5, pAT16, and K1/16 had
experienced pH changes of only 59.3, 23.7, and 50.1%, respec-
tively. The ability of HPV-16 E5 to inhibit endosomal acidifi-
cation in keratinocytes when expressed either alone or in an
HPV-16 genomic background was consistent across several
clones tested at a number of different passage levels.
Whereas Fig. 2a shows the results of this assay using G418-
selected, clonally derived cell lines, Fig. 2b shows the results of
using G418-selected mass cultures of cells at low passage so
that the effect of the vector and transfection itself could be
observed in these cells. This was necessary because the short-
lived nature of keratinocytes in tissue culture precludes the
isolation of clones without the inclusion of a transforming
gene. Normal human keratinocytes were included in both pan-
els as a baseline reference for the sake of comparison. The
endosomes of pLXSN-containing cells rapidly acidified to pH
5 (100% pH change at 10 min) at a slightly faster rate than the
normal keratinocytes, much as the pAT16E5X clones. In con-
trast, the endosomes in pLXSN16E5 cells were only 58% acid-
ified at 10 min and became only gradually more acidic with
time (66% pH change at 20 min).
These ratio-imaging studies showed a significant defect in
both the rate and extent of average endosome acidification in
E5-expressing cells compared with normal keratinocytes. The
defect in acidification appears to be greater in some cells than
in others, especially at later time points. This is apparently not
due to the effects of other HPV-16 genes, present in some of
the vectors, on the metabolism of the keratinocyte, since
pLXSN16E5 showed nearly as large a defect as pAT16 and
K1/16. The extent of the defect also seems not to correlate with
the apparent E5 mRNA levels (Fig. 1), and instead, the dif-
ferences in acidification may be due to differences in the
amount of E5 protein expressed, which is currently unknown.
Although relatively large standard errors were observed in
some of the pH measurements of E5-expressing cells, the dif-
ferences from the results for normal keratinocytes and
pAT16E5X clones were still significant. Furthermore, the mass
culture of pLXSN16E5 was significantly different from the
control vector pLXSN and normal keratinocytes. Finally, in all
cells examined the endosomes acidified to at least pH 6.3,
which is sufficient for ligand dissociation from EGF-EGFR
complexes (41). Furthermore, the apparent pKa of the EGF-
EGFR interaction is unaffected by the expression of E5 in
keratinocytes (43), and therefore, separate fates for ligand and
receptor, as reported in earlier work (42), are possible in the
E5-expressing cells examined.
Diphtheria toxin sensitivity. To determine if the pH changes
due to HPV-16 E5 would inhibit general endosomal activity,
we examined the sensitivity of normal and transfected kerati-
nocytes to the toxicity of diphtheria toxin. A lysogenic phage
infecting Corynebacterium diphtheriae, a pathogen of the upper
respiratory tract in humans, encodes the 61-kDa diphtheria
exotoxin (32). This toxin potently inhibits protein synthesis in
eukaryotes by ADP-ribosylating a diphthamide residue (a
modified histidine) of elongation factor 2 (12, 32). A single
molecule of toxin in the cytosol is enough to result in protein
synthesis inhibition and cell death (12). The entry of diphtheria
toxin into susceptible eukaryotic cells involves a receptor-me-
diated mechanism (32), and toxin activation and cytotoxicity
are dependent on the low-pH environment of endocytic vesi-
cles generated by the activity of the vacuolar H1-ATPase (47).
A pH of 5 or less is optimally required to activate the fusion of
the b subunit with the endosomal vesicle membrane, forming a
FIG. 2. Percent change in average endosomal pH over time. After the incorporation of fluoresceinated dextrans into endosomes, the pH was determined by the
ratio-imaging technique described in the text. Percent pH change was calculated as 100 3 (pH0 2 pHT/pH0 2 pHmin), where pH0 is the initial pH at time zero
(corresponding to physiological pH 7.2 to 7.5), pHT is the pH at time T of the time course, and pHmin is the minimum pH in normal keratinocytes (pH 5.0); therefore,
0% pH change represents pH $7.0, and 100% change represents pH 5.0. The data were pooled from four to seven experiments per cell type. Bars, standard errors
of the means (n, 4 to 7). (A) Normal human keratinocytes and keratinocyte clones transfected with the following vectors: pKV16E5 (which expresses E5 from the hCMV
promoter), pAT16E5X (full-length HPV-16 DNA containing a premature stop codon in E5), and pAT16 and K1/16 (separate isolates of keratinocytes transfected with
full-length HPV-16 DNA). (B) Normal human keratinocytes and mass cultures of G418-selected transfectants using pLXSN (a vector control) and pLXSN16E5 (which
expresses E5 from the Harvey murine sarcoma virus LTR).
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channel for the passage of the catalytic a subunit to the cytosol
(11, 22, 32, 38).
The diphtheria toxin sensitivity assay was adapted from ref-
erences 11 and 38. Trypsin-nicked diphtheria toxin was pre-
pared by a method adapted from references 12 and suspended
at various concentrations in growth media buffered with 20
mM HEPES (N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic
acid) (pH 7.2). For 30 min the toxin was bound to cells kept on
ice to prevent internalization of the toxin. Cells treated only
with buffered growth media were included as controls. After
washing away unbound toxin with ice-cold phosphate-buffered
saline, one of the pair of dishes was acid shocked with buffered
growth medium (20 mM HEPES, pH ,4.0) for 5 min at 378C
to measure receptor-dependent endosome-independent diph-
theria toxin sensitivity. All dishes were then incubated at 378C
for 1 h in growth media buffered to pH 7.2. After thorough
washing, the cells were labeled for 1 h with cysteine-free Dul-
becco modified Eagle medium plus 2 mCi of [35S]cysteine per
ml (1,300 Ci/mmol; Amersham; Arlington Heights, Ill.). After
unincorporated label was washed away, the cells were solubi-
lized in 200 ml of 0.1 N NaOH, and 50 ml of the solute was
blotted to 2.4-cm glass fiber disks (Whatman, Maidstone, En-
gland). Disks were washed with 10% trichloroacetic acid,
rinsed with 95% ethanol, and air dried. The incorporation of
label into the trichloroacetic acid-insoluble fraction was deter-
mined by a scintillation counter as a measure of protein syn-
thesis. The experiment was repeated three to five times in
quadruplicate for each toxin concentration.
Figure 3 shows the results of this assay, with the ability of
diphtheria toxin to inhibit protein synthesis determined in ke-
ratinocytes with and without E5. The results for the toxin-
treated cells are presented as the fraction of the incorporation
of [35S]cysteine in control cells against the toxin concentration,
so the more sensitive a cell is to diphtheria toxin, the lower the
fraction of incorporation. Normal keratinocytes (Fig. 3A) were
more sensitive to protein synthesis inhibition by diphtheria
toxin than the E5-expressing cell line pKV16E5 (Fig. 3A) at
lower concentrations of diphtheria toxin at pH 7.2. For exam-
ple, protein synthesis in normal keratinocytes was inhibited
19% by 0.01 mg of diphtheria toxin per ml, compared with only
3% inhibition in pKV16E5 cells. Similarly, pAT16E5X cells
(Fig. 3B) are also more sensitive to diphtheria toxin (24%
inhibition at 0.01 mg/ml) than pAT16 (Fig. 3B) (5% inhibition
at 0.01 mg/ml). Therefore, the expression of HPV-16 E5, re-
gardless of the promoter, interferes with the inhibition of pro-
tein synthesis by diphtheria toxin. Complete resistance to diph-
theria toxin by E5 expression was not expected, because
diphtheria toxin activation is still possible at a less than optimal
pH. Toxin activity is known to be approximately 35% of normal
at pH 6.5 compared with pH 5.0 (38), and, according to the
ratio-imaging data, endocytic vesicles do not acidify on average
below pH 6.3 in some E5-expressing cell lines, so suboptimal
activation may explain the slight reduction in protein synthesis
in these cells at higher toxin concentrations. Also, all the ke-
ratinocytes were equally sensitive to the highest toxin concen-
tration used (35 to 40% inhibition at 10 mg/ml), most likely
because of the amount of toxin present and the fact that only
one toxin molecule needs to penetrate a cell to cause cell death
(12).
It is unlikely that the difference in sensitivity between E5-
expressing and nonexpressing cells can be attributed to a dif-
ference in ability to bind diphtheria toxin. The low-pH envi-
ronment of the endosome can be mimicked by acidifying the
culture medium (11, 17, 30, 38). This acid shock allows bound
toxin to enter the cytosol through direct penetration of the
plasma membrane. When the requirement for endosome acid-
ification was bypassed, there was no difference between cell
types in their sensitivity to diphtheria toxin (data not shown).
This indicates that the number of binding sites for the toxin on
the cells with E5 is apparently similar to that on the cells
without E5 and also demonstrates that the difference in toxin
sensitivity exhibited under normal (pH 7.2) conditions is due to
differences in endosome acidification. Furthermore, it is un-
likely that the reduced sensitivity of keratinocytes is due to a
sensitive subpopulation in a culture of resistant cells, because,
with the exception of the untransfected keratinocytes, the cells
used were clonally derived. The mass cultures of pLXSN and
pLXSN16E5 were not tested in this assay.
The Vero cell line is derived from the green monkey kidney
and is typically used to study diphtheria toxin because of the
high sensitivity of the cells to low concentrations of the toxin
(Fig. 3, inset). The inclusion of these cells as a control dem-
onstrates that the assay was functioning as expected and that
human keratinocytes are at least 1,000-fold less sensitive to
diphtheria toxin than Vero cells.
Effect of chloroquine on EGFR immunofluorescence. In or-
der to investigate whether the inhibition of acidification could
explain our previous observations of decreased degradation
and the increased recycling the EGFR in E5-expressing cells
(42), we examined the effect of artificial inhibition of endoso-
mal acidification on EGFR endocytosis. Chloroquine, a weak
acidotropic base, inhibits endosomal acidification by accumu-
lating in acidic vesicles like endosomes and countering the
influx of protons, thereby increasing vesicle pH toward cyto-
plasmic levels (24, 40). For example, treatment of cells with 0.1
mM chloroquine results in an increase of vesicular pH from 4.7
to 6.4 (31). The experiment was performed in the presence and
absence of 25 mM chloroquine diphosphate (Sigma Chemical
Co., St. Louis, Mo.). EGF-starved keratinocytes were exposed
to saturating concentrations of EGF (100 ng/ml, or 16.5 nM)
while on ice to synchronize receptor-ligand complex formation.
Unbound EGF was removed, and the cells were warmed to
378C for up to 3 h to allow the internalization of EGFRs. At
various intervals the cells were fixed with 3.7% formaldehyde.
Duplicate preparations were permeablized with 0.1% Triton
X-100 to view internalized EGFR. This assay, without the use
of chloroquine, is detailed in reference 42.
At various times after the addition of EGF, the location of
EGFRs in the cell was visualized by immunofluorescence with
monoclonal antibody R1 (48) and a secondary antibody con-
jugated to fluorescein isothiocyanate. Control staining was per-
formed with secondary antibody only. Details of the staining
protocol can be found in reference 42. Figure 4 shows repre-
sentative results of this assay. At the start of the experiment the
EGFRs were present at the surface of the pAT16E5X (Fig.
4A) and pAT16 (Fig. 4B) cells, and chloroquine treatment did
not significantly alter this localization of receptor for either cell
type (Fig. 4C and D, respectively). Both cell types internalized
FIG. 3. E5-expressing cells are less sensitive to endosome-dependent diphtheria toxin-mediated protein synthesis inhibition. The ability of diphtheria toxin to inhibit
protein synthesis in keratinocytes was determined by the techniques described in the text. Protein synthesis was measured as the fraction of trichloroacetic acid-insoluble
[35S]cysteine incorporated by toxin-treated cells compared with untreated cells. Bars, standard errors of the means (n, 12 to 20). (A) Normal human keratinocytes and
keratinocyte clones transfected with pKV16E5 (expressing E5 from the hCMV promoter); (B) keratinocyte clones transfected with pAT16E5X (full-length HPV-16
DNA containing a premature stop codon in E5) or pAT16 (full-length HPV-16 DNA). The data for Vero cells (control for the efficacy of the assay) are given in the inset.
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EGFRs within 10 min in response to ligand stimulation regard-
less of the presence of chloroquine (data not shown). However,
pAT16E5X cells rapidly degraded internalized EGFRs (within
90 min) (data not shown). By 180 min post-EGF stimulation,
pAT16E5X had completely degraded internalized receptors
and showed no EGFR immunofluorescence at the cell surface
(Fig. 4E). However, pAT16 at 180 min had failed to degrade
EGFRs, which remain in intracellular vesicles, and also exhib-
its apparent recycling of receptors to the cell surface (Fig. 4F).
The recycling of receptor in pAT16 is apparent, though to a
lesser extent, at 60 min post-EGF stimulation (data not
shown). At 180 min the chloroquine-treated pAT16E5X (Fig.
4G) exhibited a pattern of EGFR retention in cytoplasmic
vesicles and had failed to degrade the internalized receptor, a
FIG. 4. Chloroquine mimics the effect of E5 expression on EGFR degradation in keratinocytes. Human keratinocytes stably transfected with pAT16E5X, a
full-length HPV-16 DNA with a premature stop codon in E5 (A, C, E, and G), or pAT16, a full-length HPV-16 DNA (B, D, F, and H), were fixed, permeabilized, and
stained for EGFRs as described in the text at time zero (A to D) or 180 min post-stimulation with EGF (E to H). Panels C, D, G, and H show cells treated with 25
mM chloroquine during the course of the experiment. Magnification, 3320.
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result much like the effect of E5 expression. However, from the
lack of surface staining for EGFR in these cells at 180 min,
chloroquine apparently did not induce recycling of internalized
receptors to the cell surface. In pAT16 cells chloroquine did
not alter recycling of EGFRs to the cell surface nor the cyto-
plasmic localization of undegraded EGFRs after 180 min (Fig.
4H), although vesicles containing EGFRs became more prom-
inent with the passage of time.
Table 1 summarizes the results of this assay for all the cell
types examined. In none of the cells examined did the addition
of 25 mM chloroquine reorganize the distribution of EGFRs
prior to stimulation with EGF. Normal keratinocytes, pLXSN
mass cultures, and pAT16E5X clones rapidly internalized
and degraded EGFRs in the absence of chloroquine, while
E5-expressing cells (mass culture pLXSN16E5 and clones
pKV16E5, pAT16, and K1/16) failed to degrade internalized
EGFR up to 3 h after EGF stimulation and exhibited recycling
of receptors to the cell surface within 60 min. Chloroquine did
not alter recycling or the cytoplasmic localization of EGFRs in
cells expressing E5 exogenously (pLXSN16E5 and pKV16E5)
or within the context of the HPV-16 genome (pAT16 or K1/
16), although EGFR-containing vesicles swelled noticeably by
180 min. At 60 and 180 min after EGF stimulation of chloro-
quine-treated normal keratinocytes, pLXSN and pAT16E5X
retained EGFRs in cytoplasmic vesicles and failed to degrade
the internalized receptor, much like the effects of E5 expres-
sion. However, from the lack of surface staining for EGFR at
60 to 180 min, it was apparent that chloroquine did not stim-
ulate recycling of internalized receptors to the cell surface in
the normal keratinocytes and pAT16E5X. In a similar exper-
iment, keratinocytes were stimulated with EGF while treated
with bafilomycin A1, a specific inhibitor of the vacuolar H1-
ATPase (1, 50). This resulted in the retention of apparently
undegraded EGFRs in cytoplasmic vesicles and the absence of
any apparent recycling (data not shown). The distribution of
receptors at 180 min was identical to that in chloroquine-
treated cells (Fig. 4G). Furthermore, there were no apparent
differences in EGFR distribution in E5-expressing cells treated
with bafilomycin A1 (data not shown).
We have shown that E5 expressed from the endogenous
HPV-16 promoter, or two different exogenous promoters, in-
hibits acidification of endosomes. The ability of chloroquine to
inhibit endosomal acidification and thereby prevent EGFR
degradation in normal keratinocytes supports the hypothesis
that the inhibition of EGFR degradation in E5-expressing cells
is due to defective acidification of endosomes. However, arti-
ficially inhibiting endosomal acidification with chloroquine did
not result in the recycling of EGFRs in normal keratinocytes as
was seen with E5-expressing cells. This is consistent with the
observation that chloroquine did not interfere with normal
recycling of proteins like transferrin receptor (40). Further-
more, results similar to the effect of chloroquine were found
after keratinocytes were treated with bafilomycin A1. From
these experiments we conclude that the inhibition of endosome
acidification can account for some, though not all, of the effects
of E5 on internalized EGFR and that the defect in acidification
in E5-expressing cells may be due to interference with the
H1-ATPase pump.
It is still unknown how the interaction of HPV-16 E5 with
the 16-kDa component of the vacuolar H1-ATPase inhibits
endosomal acidification. The most straightforward possibility
is that the function or assembly of the proton pump may be
disrupted by the binding of the E5 protein to the pump com-
plex through either hydrophobic interactions, steric hindrance,
or blockage of the proton pore that is composed, at least in
part, of 16-kDa subunits. Another potential mechanism is that
E5 may exclude the pump complex from the maturing endo-
some. This has been demonstrated as the means by which
Mycobacterium spp. prevent acidification of mycobacterium-
containing vacuoles in infected macrophages (44).
The observations presented here reinforce the proposed role
for E5 in the life cycle of HPV-16: by inhibiting endosomal
acidification to delay EGFR degradation, in combination with
being able to increase EGFR recycling and to heighten the
mitogenic response to EGF, HPV-16 E5 may boost the mito-
genic responses of host cells in the epithelium to provide the
replication machinery required for viral propagation in other-
wise differentiating keratinocytes.
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